Interaction Checker

Cookies help us deliver our services. By using our services, you agree to our use of cookies. Learn more

Changes to interactions with vernakalant

Tuesday 04 July 2023

Interactions between sorafenib and lenvatinib and vernakalant have been upgraded from green to amber owing to new data from CredibleMeds. Vernakalant is now listed as a possible risk of QT prolongation. 

Awards and commendations
bma-foundation-for-medical-research british-medical-journal-2018 queens_aniversary_prize_2017 rcp-excellence-patient-care-awards-2017 building_better_healthcare_awards_2016